Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: Early detection strategies

Urology. 1995 Aug;46(2):125-41. doi: 10.1016/s0090-4295(99)80181-2.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Biopsy, Needle
  • Humans
  • Likelihood Functions
  • Male
  • Medicare / economics*
  • Middle Aged
  • Physical Examination
  • Prostate / diagnostic imaging
  • Prostate / pathology
  • Prostate-Specific Antigen / analysis*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / economics
  • Prostatic Neoplasms / epidemiology
  • Reference Standards
  • Reimbursement Mechanisms
  • Ultrasonography
  • United States

Substances

  • Prostate-Specific Antigen